FDA Approves New Leukemia Drug

The FDA has approved a new drug used to treat chronic lymphocytic leukemia (CLL) in patients who have not been treated previously for the disease. The drug, Gazyva, is used in conjunction with chemotherapy to treat the disease. The drug is available now in the U.S., just weeks after its approval....Read Full Post
Source: About.com Cancer - Category: Cancer & Oncology Source Type: news